NIKA PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
NIKA PHARMACEUTICALS, INC. (NIKA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 13.20 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-03
- NIKA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 13.20M shares, a 0.00% change year-over-year.
- NIKA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 13.20M shares, a 0.00% change year-over-year.
- NIKA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 13.20M shares, a 0.00% change year-over-year.
- NIKA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 13.20M shares, a 0.00% change year-over-year.
- NIKA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 13.20M shares, a 0.00% change from fiscal 2020.
- NIKA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 13.20M shares, a 0.00% change from fiscal 2019.
- NIKA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 13.20M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 13.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 13.20M shares derived: average of 2 quarters · filed 2022-03-03 | 13.20M shares derived: average of 3 quarters · filed 2022-03-03 | 13.20M shares 10-K · filed 2022-03-03 |
| 2021-09-30 | 13.20M shares 10-Q · filed 2021-11-12 | 13.20M shares derived: average of 2 quarters · filed 2021-11-12 | 13.20M shares 10-Q · filed 2021-11-12 | 13.20M shares derived: average of 4 quarters · filed 2022-03-03 |
| 2021-06-30 | 13.20M shares 10-Q · filed 2021-08-11 | 13.20M shares 10-Q · filed 2021-08-11 | 13.20M shares derived: average of 3 quarters · filed 2022-03-03 | 13.20M shares derived: average of 4 quarters · filed 2022-03-03 |
| 2021-03-31 | 13.20M shares 10-Q · filed 2021-05-13 | 13.20M shares derived: average of 2 quarters · filed 2022-03-03 | 13.20M shares derived: average of 3 quarters · filed 2022-03-03 | 13.20M shares derived: average of 4 quarters · filed 2022-03-03 |
| 2020-12-31 | 13.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 13.20M shares derived: average of 2 quarters · filed 2022-03-03 | 13.20M shares derived: average of 3 quarters · filed 2022-03-03 | 13.20M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 13.20M shares 10-Q · filed 2021-11-12 | 13.20M shares derived: average of 2 quarters · filed 2021-11-12 | 13.20M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 13.20M shares 10-Q · filed 2021-08-11 | 13.20M shares 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | 13.20M shares 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | 13.20M shares 10-K · filed 2021-03-24 |